Mah Kheirabadi, PhD
About Mah Kheirabadi, PhD
Mah Kheirabadi, PhD, is an Associate Director at Entrada Therapeutics, specializing in library design and synthesis for drug discovery. He has extensive experience in oligonucleotide and peptide drug development, having held various scientific roles at notable organizations including Bristol-Myers Squibb and Neon Therapeutics.
Current Role at Entrada Therapeutics
Mah Kheirabadi serves as the Associate Director at Entrada Therapeutics, a position he has held since 2021. In this role, he is involved in overseeing various projects related to drug discovery and development. His expertise in library design and synthesis for structure-based screening contributes to the advancement of therapeutic candidates within the organization.
Previous Experience at Entrada Therapeutics
Prior to his current role, Mah Kheirabadi worked at Entrada Therapeutics as a Principal Scientist and Senior Scientist. He spent a total of 1 year as Principal Scientist from 2020 to 2021 and 9 months as Senior Scientist in 2020. His work focused on drug discovery processes, emphasizing potency, selectivity, and ADMET/PK properties.
Professional Background in Research
Mah Kheirabadi has a diverse background in pharmaceutical research, having worked at several prominent organizations. He was a Research Scientist at Bristol-Myers Squibb for 1 year in 2016-2017 and held positions at Neon Therapeutics as Senior Scientist and Senior Scientist II from 2018 to 2020. His experience includes leading oligonucleotide and peptide drug discovery projects and developing assays for evaluating small molecules and peptides.
Educational Qualifications
Mah Kheirabadi earned his Doctor of Philosophy (PhD) in Organic Chemistry from Temple University, where he studied from 2007 to 2013. He also holds a Bachelor of Science (B.Sc.) in Chemistry from Sharif University of Technology, obtained from 2002 to 2006. His academic background laid the foundation for his extensive career in drug discovery and development.
Specialization and Expertise
Mah Kheirabadi specializes in library design and synthesis for structure-based in vitro and in vivo screening. His work focuses on the potency, selectivity, and ADMET/PK properties of therapeutic candidates. He is also experienced in conjugation and labeling of oligonucleotides, peptides, proteins, and antibodies, as well as peptide GMP manufacturing and process development.